CTNNB1 and hepatocellular carcinoma: showed that HCC patients with CTNNB1 mutations did not respond to PD-1 blocking therapy, which validated the hypothesis that HCC “cold tumors” defined by Wnt/CTNNB1 mutations are not responsive to immunotherapy (28).